The Mouse Tumor Models Resource (MTMR) was established to: 1) facilitate translational research with the use of animal models for preclinical studies, and 2) consolidate animal expertise for in vivo studies using xenograft and transgenic models. The resource maintains a breeding colony of Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) mice and has established a tumor bank representing prostate cancer progression in TRAMP as well as several other widely used models of prostate cancer including the CWR22 model, HiMyc model, PBCre4VPten. In addition to prostate cancer models, MTMR also has a sarcoma model and a developing transgenic model of pancreatic cancer. The Resource has expertise in establishing xenografts from clinical samples and routinely grafts human cancer samples subcutaneously or under the renal capsule. MTMR also treats cohorts of animals, tracks tumor growth, and performs tissue procurement and post collection processing for histology and molecular analysis. MTMR offers investigators expertise in all standard small animal surgeries and procedures, including establishment of tumor xenograft (subcutaneous and subrenal), injections (iv, subQ, ip, intracardiac, intrafemoral, intraprosatatic), castration, oral gavage, maintenance of transgenic colonies, administration of specialized diets, tumor measurements and blood draws. The highly trained and experienced MTMR technical staff provide expertise in the use of in vivo models, and consolidated breeding colonies to ultimately provide high quality service at a significant cost savings to investigators. MTMR is comprised of two technicians who provide technical expertise and perform all services and two research scientists that provide oversight of operations and scientific consultation and budgetary evaluation. First priority for use is given to peer-review-funded RPCI CCSG members;second priority to non-peer-review-funded CCSG members;third priority to non-members and academic collaborators;and last priority to external users. During the reporting period, the Mouse Tumor Model Shared Resource has served 30 members from 5 research programs, with 66% utilization by CCSG members with peer reviewed funding. The CCSG support provides 18% of the overall proposed budget

Public Health Relevance

Animal models of human cancer are a vital resource in the quest to understand, prevent and cure cancer. The Mouse Tumor Model Resource provides the research community with a highly skilled staff and expertise in the appropriate use of animal models. The services provided by the Resource facilitate discovery in cancer biology and the rapid translation of bench science into in vivo studies which compliment translational clinical studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016056-37
Application #
8738385
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-06-16
Project End
2019-04-30
Budget Start
2014-06-26
Budget End
2015-04-30
Support Year
37
Fiscal Year
2014
Total Cost
$71,552
Indirect Cost
$28,302
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Zhao, Zhiguo; Wen, Wanqing; Michailidou, Kyriaki et al. (2016) Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes Control 27:679-93
Goossens, Maria E; Isa, Fatima; Brinkman, Maree et al. (2016) International pooled study on diet and bladder cancer: the bladder cancer, epidemiology and nutritional determinants (BLEND) study: design and baseline characteristics. Arch Public Health 74:30
Clyde, Merlise A; Palmieri Weber, Rachel; Iversen, Edwin S et al. (2016) Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. Am J Epidemiol 184:579-589
Wilton, John; Kurenova, Elena; Pitzonka, Laura et al. (2016) Pharmacokinetic analysis of the FAK scaffold inhibitor C4 in dogs. Eur J Drug Metab Pharmacokinet 41:55-67
Sexton, Sandra; Tulowitzki, Ryan; Jones, Craig A et al. (2016) Involvement of the renin-angiotensin system in the development of nephrogenic systemic fibrosis-like lesions in the RenTag mouse model. Clin Exp Nephrol 20:162-8
Shafirstein, Gal; Battoo, Athar; Harris, Kassem et al. (2016) Photodynamic Therapy of Non-Small Cell Lung Cancer. Narrative Review and Future Directions. Ann Am Thorac Soc 13:265-75
Pharoah, Paul D P; Song, Honglin; Dicks, Ed et al. (2016) PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations. J Natl Cancer Inst 108:
Austin, David C; Strand, Douglas W; Love, Harold L et al. (2016) NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance. Prostate 76:1004-18
Rohrbach, Daniel J; Rigual, Nestor; Arshad, Hassan et al. (2016) Intraoperative optical assessment of photodynamic therapy response of superficial oral squamous cell carcinoma. J Biomed Opt 21:18002
Chinnam, Meenalakshmi; Wang, Xiaoling; Zhang, Xiaojing et al. (2016) Evaluating Effects of Hypomorphic Thoc1 Alleles on Embryonic Development in Rb1 Null Mice. Mol Cell Biol 36:1621-7

Showing the most recent 10 out of 1099 publications